News
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...
14hon MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
21h
News-Medical.Net on MSNRare lung cell found to protect against COVID-19 deathA rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.
CANADIAN COUNTDOWN — On Monday, Canadians will head to the polls to vote in the most consequential national election in decades. Their ballots will dictate who gets to lead the government during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results